Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

British Journal of Cancer

Volumn 89, Issue 9, 2003, Pages 1661-1663

  McCredie, Mre ^a,e   Dite, G S ^b   Southey, M C ^b   Venter, D J ^b,c   Giles, G G ^d   Hopper, J L ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e New South Wales Cancer Registry   (Australia)

Author keywords

Breast cancer in young women; Epidemiology; Oestrogen and progesterone receptor status

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; RECEPTOR SUBTYPE;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BIOCHEMISTRY; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 0345303961     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601293     Document Type: Article

References (12)

1. Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins A-M, Dite GS, McCredie MRE, Giles GG, Hopper JL, Venter DJ (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 59: 2011-2017
2. Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson GA, Potischman N, Malone KE, Brogan DJ, Daling JR, Brinton LA (2002) Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am J Epidemiol 156: 507-516
3. Dite GS, Jenkins MA, Hocking JS, Giles GG, McCredie MRE, Southey MC, Venter DJ, Hopper JL (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 95: 448-457
4. Hopper JL, Chenevix-Trench G, Jolley D, Dite GS, Jenkins MA, Venter DJ, McCredie MRE, Giles GG (1999) Design and analysis issues in a population-based case - control - family study of the genetic epidemiology of breast cancer, and the Co-operative Family Registry for Breast Cancer Families (CFRBCS). Monogr Natl Cancer Inst 26: 95-100
5. Hopper JL, Giles GG, McCredie MRE, Boyle P (1994) Background, rationale and protocol for a case - control - family study of breast cancer. The Breast 3: 79-86
6. Huang W-Y, Newman B, Millikan RC, Schnell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151: 703-714
7. McCredie MRE, Dite GS, Giles GG, Hopper JL (1998) Breast cancer in Australian women under the age of 40. Cancer Causes Control 9: 189-198
8. Nomura Y, Miura S, Koyama H, Enomoto K, Kasumi F, Yamamoto H, Kimura M, Tominaga T, Iino H, Morimoto T, Tashiro H (1992) Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. Cancer 69: 153-164
9. Phillips KA (2000) Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. J Clin Oncol 18(21 Suppl): S107-S112
10. Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4: 319-326
11. Thorpe S.M. (1988) Estrogen and progesterone receptor determinations in breast cancer. Acta Oncol 27: 1-19
12. Yasui Y, Potter JD (1999) The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 10: 431-437